Search results
Results from the WOW.Com Content Network
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
Download as PDF; Printable version; In other projects ... Updated January 13, 2025. COVID-19 vaccine distribution by country [1 ] Location Vaccinated [a] Percent ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
COVID-19 vaccine production by country Country Doses (millions) 3 Mar 2021 [1] 31 Jan 2022 [2]; China 141.6: 4951.4 European Union 81.0: 2459.9 India 42.4: 1807.8
COVID-19 Vaccination Record Card: Image title: COVID-19 Vaccination Record Card: Author: CDC/NCIRD: Software used: Adobe InDesign CC 13.0 (Windows) Conversion program: Adobe PDF Library 15.0: Encrypted: no: Page size: 348 x 294 pts: Version of PDF format: 1.4
NICs are countries whose economies have not yet reached a developed country's status but have, in a macroeconomic sense, outpaced their developing counterparts. Such countries are still considered developing nations and only differ from other developing nations in the rate at which an NIC's growth is much higher over a shorter allotted time period compared to other developing nations. [3]
An analysis by Global Justice Now revealed that more than 82 percent of COVID-19 vaccines have been purchased by the wealthiest countries, accounting for just 14 percent of the world population ...
Favored distribution of vaccines within one or a few select countries, called "vaccine sovereignty", is a criticism of some of the vaccine development partnerships, [39] [42] such as for the AstraZeneca-University of Oxford vaccine candidate, concerning whether there may be [needs update] prioritized distribution first within the UK and to the ...